Compare NOTV & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | IPWR |
|---|---|---|
| Founded | 1974 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 42.8M |
| IPO Year | 1997 | 2013 |
| Metric | NOTV | IPWR |
|---|---|---|
| Price | $0.82 | $4.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $10.75 |
| AVG Volume (30 Days) | ★ 1.6M | 84.2K |
| Earning Date | 12-03-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $513,024,000.00 | $43,136.00 |
| Revenue This Year | $6.26 | N/A |
| Revenue Next Year | $45.49 | $3,233.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.54 | N/A |
| 52 Week Low | $0.66 | $3.06 |
| 52 Week High | $6.48 | $8.62 |
| Indicator | NOTV | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 51.45 |
| Support Level | $0.79 | $3.06 |
| Resistance Level | $0.95 | $4.06 |
| Average True Range (ATR) | 0.09 | 0.34 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 51.07 | 82.39 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.